Method of regulating angiogenesis using ryk protein
作者： Steve Roczniak , Alya Zolotorev , Nathalie A. Dubois-Stringfellow
DOI:
关键词: Macular degeneration 、 Biology 、 New variant 、 Cancer 、 Cancer research 、 Angiogenesis 、 Disease 、 Wound healing 、 Immunology
摘要: Ryk protein was found to have a novel activity in regulating angiogenesis. New variant proteins were constructed that useful modulating the capillary forming of endothelial cells. Variant proteins, may be employed as therpeutics diseases such cancer, wound healing, diabetic retinopathies, macular degeneration, and cardiovascular diseases, other or clinical conditions where angiogenesis is relevant causation treatment disease.
lens.org 参考文章(7)
Kari Alitalo, Luca Tamagnone, Juha Partanen, Kinya Ohgami, Elina Armstrong, Tetsushi Tazunoki, Jerzy Lasota, Kay Huebner, Sal LaForgia, The human ryk cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain. Oncogene. ,vol. 8, pp. 2009- 2014 ,(1993)
Steven Alan Stacker, Christopher Martin Inst Hovens, Andrew Frederick Wilks, Receptor-type tyrosine kinase-like molecules ,(1993)
Govindaswamy Panchamoorthy, Namit Ghildyal, Human receptor tyrosine kinase ,(1999)
Barbara L. Hempstead, Phi Wiegn, Rosemary Kraemer, Shahin Rafii, Michael J. Donovan, Methods for regulating angiogenesis and vascular integrity using trk receptor ligands ,(1999)
Michael M. Halford, Andrew C. Oates, Margaret L. Hibbs, Andrew F. Wilks, Steven A. Stacker, Genomic structure and expression of the mouse growth factor receptor related to tyrosine kinases (Ryk). Journal of Biological Chemistry. ,vol. 274, pp. 7379- 7390 ,(1999) , 10.1074/JBC.274.11.7379
Laura K. Shawver, Kenneth E. Lipson, T. Annie T. Fong, Gerald McMahon, Greg D. Plowman, Laurie M. Strawn, Receptor tyrosine kinases as targets for inhibition of angiogenesis Drug Discovery Today. ,vol. 2, pp. 50- 63 ,(1997) , 10.1016/S1359-6446(96)10053-2
Andrew Frederick Wilks, Stephen Alan Stacker, Assay receptor proteins and ligands ,(1995)